Australian (ASX) Stock Market Forum

previous Ann was : OUTSTANDING SUBB2M OVARIAN CANCER TEST DATA

and that saw some 70% uplift...

Today's one was only : EXCELLENT SUBB2M BREAST CANCER TEST DATA

and it only is up another 50%. Now close to $2.56

Griffith University releases additional data on BARD1’s SubB2M technology showing 100% specificity and over 95% sensitivity for detection of all stages of breast cancer
• BARD1 aims to develop and commercialise SubB2M-based blood tests for breast cancer to enable earlier detection, inform treatment decisions and improve women’s health outcomes
 
No idea whether its a good business or not as I havent spent any time on it, but as someone who's wife has had breast cancer, its certainly a very exciting product that has enormous potential to have a massive impact on one of the most common cancers.
 
No idea whether its a good business or not as I havent spent any time on it, but as someone who's wife has had breast cancer, its certainly a very exciting product that has enormous potential to have a massive impact on one of the most common cancers.
too true. And Ovarian cancer is even more insidious.
 
The kind of Chart we all dream about. Well done to anyone who was on Bard.

And well done the Company for hopefully being on the way to helping change so many peoples lives for the better. :cool:




1613365942613.png
 
sold 100000 of these @3.9 c 15 months ago, buggar

Not as bad as it sounds hopefully Aus?

They had a 30:1 consolidation not long ago I think? So 3.9 cents would have become 3,333 Shares at $1.17 per share

They were recently trading as low as 57 cents post consolidation (1.9 cents pre consolidation :nailbiting: ) so a bit of tension of you were still holding!

Bio Stocks are high risk high reward scenarios of course. Guts and glory and all that stuff.:chicken::grumpy::arghh:
 
Thanks @barney just saw your earlier post.

Didn't look into it as it's too late to matter.
Cheers
All good Aus-t Just didn't want you thinking you'd lost a fortune :nailbiting:

Pushed as high as $5.60 this morning but the inevitable profit taking kicked in.

Currently $4.50 there will be a bit of roller coasting still to come I'd say.
 
4 months on and the Share price has plummeted since the announcement of legal proceedings.

Ex Company representatives squabbling over their share of the spoils and ruining it for the rank and file Holders

Well done boys :spitoutdummy: (DNH)


Web capture_17-6-2021_12110_www2.commsec.com.au.jpeg



1623896254992.png
 
New member getting, used to the forum and started a new thread instead of adding to this one, so have copied here.

I have traded since February and a bit down, despite this have had some excellent announcements in the detection of cancer field,
Achievement of this key POC milestone supports and de-risks advancing the development of SubB2M ELISA tests for ovarian, breast, prostate and other cancers
Biggest issue is an ongoing legal proceedings:
24 February 2021 in relation to the legal proceedings commenced in the Supreme Court of Victoria against the Company by Tony Walker and former founding scientist of the Company, Dr Irmgard Irminger-Finger (Plaintiffs and, together, the Claim). The Company has received from the Plaintiffs particulars, and proposed means of calculation, of their alleged loss and damages relating to the Claim and is reviewing it with its legal advisers. Although the calculations derive a potentially very significant amount of claimed loss and damage by the Plaintiffs, any such claim will ultimately turn on the evidence and the outcome of the legal proceedings at trial. The Company continues to dispute the basis of the Claim and has filed with the Supreme Court of Victoria a comprehensive defence.
I have researched the legal proceeding and am of the belief that Bard will either win the case or if the lose the amount award will not be significant. Of course I have no legal experience and am not a lawyer, just my logic. So take with a grain of salt.
Despite this the SP does appear to have bottomed and is showing signs of life, with a good announcement a sudden rise would not surprise me. DYOR.
 
yep there is a little bit of a learning curve , but i had my missteps as well after joining , so no need to feel embarrassed
 
On December 9th, 2021, Bard1 Life Sciences Limited (BD1) changed its name and ASX code to INOVIQ Ltd (IIQ).
 
Top